Avanos Medical, Inc. AVNS is well poised for growth in the coming quarters, backed by its impressive product line. A solid third-quarter 2022 performance, along with a continued focus on its ...

Last year, Avanos' respiratory device department brought in just under $136 million in net sales, down nearly 14% from the previous year, according to the company's full-year earnings report.

In May, Avanos reported it generated $191.7 million in revenue, down 3 percent from a year earlier. Sales for the respiratory business declined more than 14 percent to $32.4 million, ...

Avanos had disappointing Q1 results, with net sales at $191.7 million, down 2.9% year over year. It also posted a net loss of $500,000, compared to a net income of $5.4 million a year ago.

On April 18, 2025, Avanos Medical announced the departure of Michael C. Greiner, who had served as Interim CEO and previously as CFO and Chief Transformation Officer. Greiner’s exit follows the ...

Avanos Medical, Inc. (NYSE:AVNS) is a medical technology company that offers medical device solutions. The one-month return ...

Avanos announces retirement of CEO Joe Woody, Michael Greiner named interim CEO October 30, 2024 — 06:55 am EDT Written by TheFly for TipRanks -> ...

Avanos will additionally pay Greiner a prorated bonus for 2025. He will remain with the company in a consulting capacity until May 16, for which he will receive a $50,000 payout.

ALPHARETTA, Ga., June 9, 2025 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) a leading medical technology company focused on delivered innovative healthcare solutions, today announced the ...